Sun Pharmaceutical Industries Limited and Checkpoint Therapeutics, had announced that they have entered into an agreement by which Sun Pharma will acquire Checkpoint, an immunotherapy and targeted oncology company. Dilip Shanghvi, Chairman & Managing Director of Sun Pharma, said,…

  Jazz Pharmaceuticals  and Chimerix , had announced the companies have entered into a definitive agreement for Jazz to acquire Chimerix for $8.55 per share in cash, representing a total consideration of approximately $935 million. The transaction has been approved…